Global New Traditional Chinese Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global New Traditional Chinese Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
New Traditional Chinese Medicine refers to a new type of medicine developed through innovative research and development based on traditional Chinese medicine or Chinese herbal formulations. It may contain not only the traditional Chinese medicine ingredients, but also synthetic chemical Compounds or natural substances, as well as processed and extracted Chinese medicine ingredients. The research and development of Chinese medicine innovative drugs follows the standards and procedures of modern drug development, using modern scientific techniques to screen, extract, and isolate the ingredients of Chinese herbal formula ations in order to achieve more significant therapeutic effects, fewer side effects, and better absorption and utilization by the human body. The development of these drugs plays an important role in promoting the modernization and internationalization of traditional Chinese medicine.
New Traditional Chinese Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global New Traditional Chinese Medicine market is projected to reach US$ 5072.6 million in 2034, increasing from US$ 3561 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Online Sales and Offline Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for New Traditional Chinese Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, New Traditional Chinese Medicine key companies include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly are top 3 players and held % share in total in 2022.
New Traditional Chinese Medicine can be divided into Innovative Traditional Chinese Medicine, Improved New Drug of Traditional Chinese Medicine and Traditional Chinese Medicine Compound Preparation,, etc. Innovative Traditional Chinese Medicine is the mainstream product in the market, accounting for % share globally in 2022.
New Traditional Chinese Medicine is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the New Traditional Chinese Medicine industry development. In 2022, global % share of New Traditional Chinese Medicine went into Online Sales filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global New Traditional Chinese Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Innovative Traditional Chinese Medicine
Improved New Drug of Traditional Chinese Medicine
Traditional Chinese Medicine Compound Preparation
Online Sales
Offline Sales
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the New Traditional Chinese Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, New Traditional Chinese Medicine introduction, etc. New Traditional Chinese Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of New Traditional Chinese Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
New Traditional Chinese Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global New Traditional Chinese Medicine market is projected to reach US$ 5072.6 million in 2034, increasing from US$ 3561 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Online Sales and Offline Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for New Traditional Chinese Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, New Traditional Chinese Medicine key companies include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly are top 3 players and held % share in total in 2022.
New Traditional Chinese Medicine can be divided into Innovative Traditional Chinese Medicine, Improved New Drug of Traditional Chinese Medicine and Traditional Chinese Medicine Compound Preparation,, etc. Innovative Traditional Chinese Medicine is the mainstream product in the market, accounting for % share globally in 2022.
New Traditional Chinese Medicine is widely used in various fields, such as Online Sales and Offline Sales, etc. Online Sales provides greatest supports to the New Traditional Chinese Medicine industry development. In 2022, global % share of New Traditional Chinese Medicine went into Online Sales filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global New Traditional Chinese Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Innovative Traditional Chinese Medicine
Improved New Drug of Traditional Chinese Medicine
Traditional Chinese Medicine Compound Preparation
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the New Traditional Chinese Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, New Traditional Chinese Medicine introduction, etc. New Traditional Chinese Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of New Traditional Chinese Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices